The objective of this paper was to study the in vitro and in vivo inhibitory effect of Bidens bipinnata L. extract on growth of cervical carcinoma U14 cells. MTT method was used to determine the inhibitory effect of Bidens bipinnata L. extract on U14 tumour cells, and the effects of Bidens bipinnata L. extract on inhibition rate of solid tumour and life prolongation rate of ascites tumour were observed through the establishment of two animal models of mouse cervical carcinoma U14 solid tumour and ascites tumour. In the in vitro MTT assay, the inhibition rate gradually increased with the increase of dose of Bidens bipinnata L. and the extension of time. Its inhibition rate was 70.44% at a concentration of 80μg/L. Solid tumour inhibition rates in the high-and low-dose groups and cisplatin group were 49.13%, 2.26% and 75.72% respectively; life prolongation rates in each ascites tumour group were 63.63%, 34.86% and 87.34% respectively. The Bidens bipinnata L. extract has a certain inhibitory effect on growth of mouse cervical carcinoma U14.
Introduction
Bidens bipinnata L. is a plant in the genus Bidens of the family Asteraceae, which is also known as Popozhen, Guichacao, Mangchangcao, and Yinxianbao, It is produced in the northeast, north, east, southwest regions, as well as Shaanxi, Gansu provinces of China, and is grown on the roadsides, wastelands, hillsides and fields. Bidens bipinnata L. is initially recorded in a Chinese classical pharmaceutical book "Bencao Shiyi" as bitter in taste, lightly sweet, slightly cold, and non-toxic. Its main effects are heat-clearing and detoxifying, anti-diarrhoeal, stasis-eliminating and anti-swelling, and is mainly used in the treatment of malaria, diarrhoea, dysentery, hepatitis, acute nephritis, stomach-ache, traumatic injury, snake and insect bites, etc. ).
As a traditional Chinese ancient medicine, Bidens bipinnata L. contains multiple chemical constituents, and has a wide range of biological activities and clinical efficacies. Its main chemical constituents include flavonoids, enynes, coumarins, organic acids and their esters, triterpenes, sterols, volatile oils, as well as a few amino acids and trace elements (Yang et al., 2009; Zhang et al., 2004) . It has been found in recent years that the Bidens bipinnata L. can be used for antioxidation, anti-bacteria, anti-inflammation, anti-malaria, anti-tumour, and for the treatment of colds, goitre, chronic pelvic inflammation, annex inflammation, uterine prolapse, and neurasthenia. It also has relatively good curative effects on primary hypertension, thrombosis prophylaxis and diabetes (Qian et 
Materials and Methods

Drugs and Reagents
Bidens bipinnata L. (AF-2012-BHF) decoction pieces (Jiangxi Nanhua Medicine Co., Ltd.), which was identified by Dr Sun JH; cisplatin (Kunming Guiyan Pharmaceutical Co., Ltd.) 
U14 Tumour Lines
Purchased from the KeyGEN Biotech Co., Ltd.
Preparation of Bidens bipinnata L. extract
50g of Bidens bipinnata L. powder was weighed, added with a 15-fold volume of 80% ethanol, and ultrasonically extracted three times with 30 min each time, followed by suction filtration. After the filtrates were combined, cryoconcentrated, and freeze dried, Bidens bipinnata L. extract powder was obtained.
Determination of effect of Bidens bipinnata L. extract on U14 cell proliferation by MTT assay
Cervical carcinoma U14 cells were cultured in DMEM medium containing 10% foetal bovine serum, and incubated in a constant temperature incubator at 37℃ with 5% CO2. Cells were collected in the logarithmic growth phase. The logarithmic growth phase U14 cells were diluted to a concentration of 1×10 6 cells/ml and seeded in 96-well plates with the addition of different concentrations of Bidens bipinnata L. extracts (5, 10, 20, 40, 80μg/L). The one without addition of the drug was also prepared as the blank group. Cells were cultured for 24, 48, 72 h respectively, then added with MTT, and cultured for another 4 h. After that, culture medium was discarded; DMSO was added and the plates were shaken. Optical density (OD) value was measured at 570 nm with a microplate reader, and cell growth inhibition rate was calculated according to the formula. The calculation was repeated three times and averaged. The formula is as follows: Cell inhibition rate = (1 -average OD value of experimental group / average OD value of control group) × 100% Establishment of U14 tumour-bearing mice model 0.5 ml of well-grown mouse cervical carcinoma U14 cell suspension was injected into the peritoneal cavities of mice, and passaged in their peritoneal cavities. When the passaged mouse ascites turned white, ascites were collected and diluted to a 1×10 7 cells/ml tumour cell suspension with sterile 0.9% saline. 32 Kunming mice were all inoculated in the right armpit with 0.2 ml of U14 mouse cervical carcinoma cell suspension having a concentration of 1×10 7 cells/ml, and weighed immediately after inoculation.
Establishment of ascites tumour model
Under aseptic conditions, U14 tumour cells passaged in the Kunming mice were taken and 0.2 ml of U14 mouse cervical carcinoma cell suspension with a concentration of 1×10 7 cells/ml was intraperitoneally injected in each mouse. Inoculation success rate was 100%.
Grouping of animal models
32 Kunming mice were randomly divided into four groups, with each group containing 8 mice. Four days later, after the tumours grew to the size of a rice grain, grouped administration was begun: model control group was administered by intraperitoneal injection of 0.2ml of sterile saline per mouse every other day, cisplatin group was administered by intraperitoneal injection of 3mg/ml cisplatin every other day, Bidens bipinnata L. extract high-dose group was intragastrically administered 10 g/kg Bidens bipinnata L. extract everyday, and Bidens bipinnata L. extract low-dose group intragastrically administered 5 g/kg Bidens bipinnata L. extract everyday. After 10 days of consecutive administration, models were successful. On the eleventh day after administration, the mice were sacrificed by cervical dislocation, weighed, and tumour inhibition rate was calculated. The calculation formula is as follows: Tumour inhibition rate (%) = average tumour weight of control group -average tumour weight of administration group / average tumour weight of control group × 100%
Determination of ascites tumour life prolongation rate
After discontinuation of administration, number of survival days of mice was observed, and life prolongation rate of mice was calculated. The calculation formula is as follows: Life prolongation rate (%) = (mean survival days of administration group -mean survival days of control group) / mean survival days of control group × 100%.
Statistical Methods
All data were statistically analysed using one-way ANOVA in SPSS 13.0 statistical software.
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Results
Determination of effect of Bidens bipinnata L. extract on proliferation of cervical carcinoma U14 cells by MTT assay
Bidens bipinnata L. extract significantly inhibited the proliferation of cervical carcinoma U14 cells in a dose-and time-dependent manner. Within the same time, inhibitory effect was gradually enhanced with the increase of dose; at the same dose, inhibitory effect was gradually increased with the extension of time, as shown in Figure1   Figure 1 : Extract on proliferation of cervical carcinoma U14 cells
Effect of Bidens bipinnata L. extract on tumour inhibition rate in U14 tumour-bearing mice
As can be seen from Table 1 , compared with control group, Bidens bipinnata L. dose groups all had different degrees of inhibitory effects on U14 solid tumour. Tumour weights of high-and low-dose groups were significantly lower than that of the control group. The effect was obvious and the difference was statistically significant. 
Effect of Bidens bipinnata L. extract on life prolongation rate
As can be seen from Table 2 , mice in the two Bidens bipinnata L. extract dose groups show a life prolongation rate of 34.86% and 63.62% respectively. The statistical analysis revealed significant difference (P<0.01) for the two Bidens bipinnata L. extract dose groups and cisplatin group when compared with the control group. 
